Patent details

LUC00218 Product Name: lumasiran

Basic Information

Publication number:
LUC00218
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP191826163
Legal Status:
Inactive
Application number:
LUC00218
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1496
Marketing Authorization Type:
Marketing Authorization Date:
23/11/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
18/08/2021
First Marketing Authorization date:
23/11/2020
Grant date:
07/10/2022
Activation date:
Publication date:
20/08/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
23/11/2035
SPC Extension Expiration:
23/11/2035
Rejection date:
Withdrawal date:

Owner

From:
18/08/2021
 
 

Name:
Dicerna Pharmaceuticals, Inc.
Address:
33 Hayden Avenue, Lexington, Massachusetts 02421, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/08/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/10
Publication date:
01/09/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2022/12
Publication date:
08/11/2022
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
01/01/2035
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
18/08/2021 Marketing authorization 3
18/08/2021 Application Form 3
18/08/2021 MA publication 12
18/08/2021 Summary of the product caracteristics 28
20/08/2021 Outgoing Correspondence 1
20/08/2021 Publication 1
07/10/2022 Publication 1
07/10/2022 Certificate 1
10/10/2022 Outgoing Correspondence 1